Sunshine Biopharma
SBFM
7 hedge funds and large institutions have $3.55M invested in Sunshine Biopharma in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.56M |
| 2 |
EAM
Empery Asset Management
New York
|
+$1.12M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$779K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.7K |
| 5 |
Jane Street
New York
|
+$48.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $1.56M | +$1.56M | +32 | New |
|
|
EAM
2
Empery Asset Management
New York
| $1.1M | +$1.12M | +23 | New |
|
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| $720K | +$779K | +16 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $49K | +$48.7K | +1 | New |
|
|
VF
5
Virtu Financial
New York
| $34K | +$48.7K | +1 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $32K | +$48.7K | +1 | New |
|
|
7
Jane Street
New York
| $31K | +$48.7K | +1 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $10K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
10
National Bank of Canada
Montreal,
Quebec, Canada
| $3K | – | – | – |
|
|
S
11
SignatureFD
Atlanta,
Georgia
| $1K | – | – | – |
|
|
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $194 | – | – | – |
|
SBFM Hedge Fund Activity: Q1 2022 in Review
7 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q1 2022, worth a combined $3.55M.
Buyers outnumbered sellers: 7 funds opened new SBFM positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.56M.
- 7 institutional investors held Sunshine Biopharma (SBFM) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $3.55M of Sunshine Biopharma stock for Q1 2022.
- 7 funds opened new Sunshine Biopharma positions in Q1 2022 and 0 closed out, a net change of +7 holders.
- The largest Sunshine Biopharma buyer in Q1 2022 was Armistice Capital, an estimated $1.56M added.
Based on aggregated 13F filings for Q1 2022.